Roche Arthritis drug Actemra is being used to Combat COVID-19 in China.


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Roche Arthritis drug Actemra is being used to Combat COVID19 in China.
Roche has donated $2 million worth of Actemra to China before the anti-inflammatory med was officially added to Chinese authorities COVID-19 treatment guidelines.

It was noticed that the patients who are severely affected by the coronavirus, can develop uncontrolled immune syndrome. It may lead to life-threatening damage to their lung tissue. To tackle this issue, Chinese Authorities recently find out that Roche's arthritis drug Actemra is working wonderfully.

US FDA first approved Acterma for rheumatoid arthritis, now this drug proved to be very useful for the treatment of serious coronavirus patients. Recently China's National Health Commission also accepted the fact.

Roche confirmed that it had donated nearly $2m-worth of Actemra to China to fight COVID-19 outbreak, which at last count has claimed almost 3,200 lives out of more than 93,000 cases, 80,000 of them within China where the virus is thought to have originated.

In the meantime, Takeda and Alnylam also working on drug treatments to tackle COVID-19 infections.

Tags : #Roche #Coronavirus #Arthritisdrug

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026